LISTSERV mailing list manager LISTSERV 16.5

Help for SCIENCE-FOR-THE-PEOPLE Archives


SCIENCE-FOR-THE-PEOPLE Archives

SCIENCE-FOR-THE-PEOPLE Archives


SCIENCE-FOR-THE-PEOPLE@LIST.UVM.EDU


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

SCIENCE-FOR-THE-PEOPLE Home

SCIENCE-FOR-THE-PEOPLE Home

SCIENCE-FOR-THE-PEOPLE  May 1999

SCIENCE-FOR-THE-PEOPLE May 1999

Subject:

Sign-on letter to Al Gore regarding his opposition to African access to essential medicines

From:

Aram Falsafi & Wendy Call <[log in to unmask]>

Reply-To:

Science for the People Discussion List <[log in to unmask]>

Date:

Mon, 17 May 1999 23:53:20 -0400

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (293 lines)

[Something to remember when the primaries come around next spring. -Aram]

James Love <[log in to unmask]> on 05/14/99 04:01:26 PM

Please respond to [log in to unmask]

To:   Multiple recipients of list INFO-POLICY-NOTES
      <[log in to unmask]>
cc:    (bcc: Aram Falsafi)
Subject:  Sign-on letter to Vice President Gore regarding his opposition to African access to essential medicines




*****************************************************************
     Sign-on letter to Vice President Gore regarding his
     opposition to African access to essential medicines
*****************************************************************

**   Over the past three years public health groups have
     repeatedly petitioned Vice President Gore (co-chair of the
     US/South Africa Binational Commission) and US trade
     organizations to stop pressuring South Africa and other
     developing countries over to access to medicines.

**   The disputes involve complex intellectual property and trade
     matters.  In essence, the US government is demanding that
     South Africa, India, Thailand and many other countries not
     enact provisions in WTO/TRIPS rules on intellectual property
     that would lower drug prices.  The US position is that WTO
     rules regarding protection of patent rights are not high
     enough.

**   Africa is suffering from a mind boggling public health
     emergency.  According to the US Surgeon General, in nine
     south African nations, 20% to 26% of people between the ages
     of 15 and 49 are infected with HIV/AIDS.  The disease is
     also widespread and growing in Thailand, India and other
     parts of the world, and is associated also with new
     epidemics in tuberculous, meningitis and other diseases.
     Public health authorities believe this is creating new
     treatment resistance strains of infectious illnesses.

**   So far all efforts to change US policy have failed.  On
     April 30, 1999, Vice President Gore authorized the USTR to
     issue a sweeping new review of South Africa policies on
     compulsory licensing, parallel imports and approval of
     generic drugs such as Taxol.  Among other things, the US
     government is officially punishing South African for
     permitting its public health officials to speak out on
     trade and intellectual property issues in the World Health
     Organization.

**   Public health groups now are trying to reach a broader
     audience.  We are asking for signatures on the following
     letter to the Vice President.  We hope we can raise enough
     public awareness in this issue that the Vice President will
     be forced to change US policy. Please help circulate this
     important letter.

     James Love <[log in to unmask]> 202.387.8030
               http://www.cptech.org

If you are willing to sign, please send the following information
to James Love by mail <[log in to unmask]> or by fax 202.234.5176.

Yes, include my name:
Name:
Title (optional):
Affiliation (optional):
City, State, Country:

(For more info, see http://www.cptech.org/ip/health/sa
signatures will be accepted through June 30, 1999)

<-----the sign-on letter to Vice President Gore------>

Dear Vice President Gore,

     We are writing to express opposition to trade pressures you
are bringing against the people of South Africa over their
struggle to obtain access to essential medicines.

     The White House dispute with South Africa concerns three
basic points.

1.   The South Africa government has indicated it wants to use
     compulsory licensing of medical patents to produce cheaper
     copies of HIV drugs and other essential medicines.  This is
     of course legal under the WTO/TRIPS agreement, subject to
     Article 31 safeguards.

2.   The South Africa government wants to authorize "parallel
     imports" of pharmaceuticals, so that it can buy drugs in the
     United States, Europe or elsewhere, in order to get the best
     world price.  As you know, parallel importing of
     pharmaceuticals is legal under Article 6 of the WTO/TRIPS
     agreement, and is a common practice in Europe.

3.   The South African government has approved generic versions
     of Taxol, a US government invention for treating cancer.


     As co-chairman of the US/South Africa Binational Commission
(BNC) you have authorized a wide range of trade pressures against
South Africa, much of which is documented in a February 5, 1999
report to the Congress by the US Department of State.
(See:http://www.cptech.org/ip/health/sa/stdept-feb51999.html).

     Despite increasing criticism of the US bilateral pressures
on South Africa, here and internationally, your office has
authorized new trade pressures against South Africa on April 30,
1999.  (http://www.cptech.org/ip/health/sa/sa301-ap99.html)

     The April 3 "in many southern African countries, HIV/AIDS
has become an unprecedented emergency, with 20% to 26% of people
between the ages of 15 and 49 infected." 0, 1999 announcement of
a Special 301 out-of-cycle review of trade pressures against
South Africa ignored every shred of information that has been
provided to your office by public health groups.  Indeed, this
most recent announcement is basically a recycled version of the
February 16, 1999 submissions by the Pharmaceutical Research and
Manufactures Association (PhRMA), the trade association that
represents giant drug companies like Bristol-Myers Squibb, Glaxo,
Pfizer, and Johnson and Johnson that are trying to stop South
Africa from implementing policies to cut costs for
pharmaceuticals in South Africa.

     It is shocking that the US government is adapting such an
aggressive trade policy on behalf of US pharmaceutical companies,
when all of sub-Saharan Africa is confronted with a public health
crisis of historical dimensions.  The US Surgeon General, Dr.
David Satcher, recently wrote in the Journal of the America
Medical Association that "HIV/AIDS can be likened to the plague
that decimated the population of Europe in the 14th century."
Dr. Satcher says that "in many southern African countries,
HIV/AIDS has become an unprecedented emergency, with 20% to 26%
of people between the ages of 15 and 49 infected."

     This is a here-and-now emergency.  It is not a hypothetical
or potential emergency.  These people will die without access to
pharmaceutical drugs.

     Your response to this emergency should be to find ways to
save lives.  But look what you are doing.

**   You are aggressively seeking the repeal of legislation in
     South Africa that would permit that country to do what
     nations in Europe do, use parallel imports to buy drugs at
     the best world price.  South Africa wants to use market
     forces to cut drug costs.  You are pushing to protect
     pharmaceutical companies from global competition, thereby
     forcing the South Africa people to pay premiums to buy
     drugs.

**   You are punishing South Africa for even speaking out in
     favor of compulsory licensing of HIV/AIDS and other
     essential medicines.  The April 30, 1999 report on South
     Africa complains that:

          During the past year, South African
          representatives have led a faction of nations
          in the World Health Organization (WHO) in
          calling for a reduction in the level of
          protection provided for pharmaceuticals in
          TRIPS.

     In fact, everything South Africa is seeking to do is legal
     under the WTO/TRIPS agreement, so this and countless other
     statements by US government officials are bald lies.  But
     regardless, the exercise of free speech in international
     forums is an astonishing basis for trade sanctions.  As an
     elected official, indeed, as a human, how would you act if
     20 percent of all sexually active young people in the United
     States were infected with a fatal disease, and a foreign
     country was trying to prevent you from purchasing drugs on
     the global market to save money, and was preventing you from
     licensing firms to manufacture life saving medicines?  Would
     you simply show up at the World Health Assembly and docilely
     applaud the actions of that country?  Even if that foreign
     country was engaged in a relentless public relations
     campaign to label every legal action as a form of piracy or
     lawlessness?  At what point would you have the guts to tell
     the world the truth, and to speak out on behalf of millions
     of infected young men and women?

**   You are punishing South Africa for giving approval to
     generic versions of Taxol, a cancer drug that was invented
     by the US government.  There are aspects of the US
     government complaint about Taxol that are absurd, on
     technical grounds, such as the insistence that South Africa
     extend longer periods of data exclusivity than are required
     in the United States.  But the larger issue is more basic.
     Why on earth should Vice President Al Gore or any other US
     government employee seek to prevent global competition for
     Taxol, a life saving cancer drug that was invented and
     developed by the US National Institutes of Health?  Taxol
     was in NIH sponsored Phase III trials before the Bush
     Administration gave BMS exclusive rights to use NIH research
     for drug approvals.  What is the moral basis for extending
     the BMS monopoly on Taxol in a country that is so poor?


     As the Vice President of the United States you are in a
position to do much good or much harm in the world.  US voters
will soon be asked to determine if you should be the next
President of the United States.  Please explain why they should
choose you.


    Sincerely,


James Love
Director
Consumer Project on Technology

Dr. Bernard P





écoul
Project Director
Access to Essential Drugs
Médecins Sans Frontières

Joelle Tanguy
Executive Director
Doctors Without Borders/Medecins Sans Frontieres USA

Eric Sawyer
Executive Director
HIV/AIDS Human Rights Project

Kim Nichols
Development Director
African Services Committee, Inc.

Bas van der Heide
Director
Health Action International Europe

Beryl Leach
Africa Program Coordinator
Health Action International

Lori Wallach
Director
Global Trade Watch

Professor Richard Laing
Boston University

Robert Weissman
Co-Director
Essential Action

David Scondras
President
Search for a Cure

Bob Lederer
Senior Editor
POZ Magazine

Steve Suppan, PhD
Director of Research
Institute for Agriculture and Trade

Axel Delmotte
Act Up - Paris

Professor Patrick Bond
University of the Witwatersrand
Graduate School of Public and Development Management
Johannesburg, South Africa

Clarence Mini, MD
Treatment Action Campaign
Johannesburg, Gauteng Province, South Africa


Ellen 't Hoen
International Drug Policy Consultant
Amsterdam, The Netherlands

--
James Love, Director, Consumer Project on Technology
I can be reached at [log in to unmask], by telephone 202.387.8030,
by fax at 202.234.5176. CPT web page is http://www.cptech.org

Top of Message | Previous Page | Permalink

Advanced Options


Options

Log In

Log In

Get Password

Get Password


Search Archives

Search Archives


Subscribe or Unsubscribe

Subscribe or Unsubscribe


Archives

May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005
December 2004
November 2004
October 2004
September 2004
August 2004
July 2004
June 2004
May 2004
April 2004
March 2004
February 2004
January 2004
December 2003
November 2003
October 2003
September 2003
August 2003
July 2003
June 2003
May 2003
April 2003
March 2003
February 2003
January 2003
December 2002
November 2002
October 2002
September 2002
August 2002
July 2002
June 2002
May 2002
April 2002
March 2002
February 2002
January 2002
December 2001
November 2001
October 2001
September 2001
August 2001
May 2001
March 2001
February 2001
January 2001
December 2000
November 2000
October 2000
September 2000
August 2000
July 2000
May 2000
April 2000
March 2000
February 2000
January 2000
December 1999
November 1999
October 1999
September 1999
August 1999
July 1999
June 1999
May 1999
April 1999
March 1999
February 1999
January 1999
December 1998
November 1998
September 1998
August 1998
July 1998
June 1998
May 1998

ATOM RSS1 RSS2



LIST.UVM.EDU

CataList Email List Search Powered by the LISTSERV Email List Manager